BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2360465)

  • 21. The antitumoral action of polyamine linked cyclophosphazenes on human malignant glioma heterografts in nu/nu mice.
    Darcel F; Chatel M; Gautris P; Labarre JF
    Anticancer Res; 1990; 10(6):1563-9. PubMed ID: 2285228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sterols in cerebrospinal fluid during nitrosourea chemotherapy of human brain tumors.
    Fumagalli R; Pezzotta S; Racca AR; Paoletti P
    Pharmacol Res Commun; 1976 Apr; 8(2):127-41. PubMed ID: 1028078
    [No Abstract]   [Full Text] [Related]  

  • 23. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
    Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response variability of human brain tumors to AZQ in tissue culture.
    Kornblith PL; Rosa L; Bona JD; Edwards JA; Matuzic N; Hirschfeld A; Hawkins C
    J Neurooncol; 1986; 4(1):49-54. PubMed ID: 3746385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.
    Calvo FA; Pastor MA; Dy C; Alegría E; Antón Aparicio LM; Gil A; Harguindey S; Zubieta JL; Martinez Lage M
    Am J Clin Oncol; 1985 Jun; 8(3):200-9. PubMed ID: 4050738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Chemotherapy of malignant glioma.
    Walker MD
    Proc Natl Cancer Conf; 1972; 7():817-21. PubMed ID: 4271815
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.
    Allen JC; Bloom J; Ertel I; Evans A; Hammond D; Jones H; Levin V; Jenkin D; Sposto R; Wara W
    Semin Oncol; 1986 Mar; 13(1):110-22. PubMed ID: 3513315
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognitive functioning in long-term survivors of high-grade glioma.
    Archibald YM; Lunn D; Ruttan LA; Macdonald DR; Del Maestro RF; Barr HW; Pexman JH; Fisher BJ; Gaspar LE; Cairncross JG
    J Neurosurg; 1994 Feb; 80(2):247-53. PubMed ID: 8283263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-Term Efficacy of BCNU Wafers for Malignant Gliomas].
    Arakawa Y
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):690-3. PubMed ID: 27459746
    [No Abstract]   [Full Text] [Related]  

  • 31. New drugs and new delivery techniques.
    Feun LG; Lee YY; Wallace S; Charnsangavej C; Savaraj N; Carrasco CH; Gianturco C; Yung WK
    Prog Exp Tumor Res; 1985; 29():131-9. PubMed ID: 2416007
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of brain tumors.
    Wilson CB
    Adv Neurol; 1976; 15():361-7. PubMed ID: 937156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
    Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for malignant gliomas.
    Kornblith PL; Walker M
    J Neurosurg; 1988 Jan; 68(1):1-17. PubMed ID: 3275753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy in malignant brain gliomas.
    Hildebrand J
    Recent Results Cancer Res; 1978; 68():408-11. PubMed ID: 752877
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro drug sensitivity testing in human gliomas.
    Kimmel DW; Shapiro JR; Shapiro WR
    J Neurosurg; 1987 Feb; 66(2):161-71. PubMed ID: 3543252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant nitrosourea therapy for glioblastoma.
    Brisman R; Housepian EM; Chang C; Duffy P; Balis E
    Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cisplatinum for treatment of malignant glioma.
    Witman G; Cadman E; Kapp D; Wagner F
    Med Hypotheses; 1982 Apr; 8(4):335-41. PubMed ID: 7201562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.